← Leaderboards
Namrata Singh
University Of Washington
$949,962
Attributed
$949,962
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $316.4K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$949,962 · 2
By mechanism
K23$661,334 · 1
R03$288,628 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Nancy R Temkin$9,931,540
- Evan D Kharasch$17,406,013
- King Kennard Holmes$42,208,763
- Donald Lee Weaver$8,806,953
- Aaron Robert Lyon$7,315,389
Others in their field
Other Rising Stars on “Mortality”
- Suma Babu · Massachusetts General Hospital$11,004,714
- Sabrina Paganoni · Massachusetts General Hospital$11,004,714
- Carolina Porras · Fundacion Inciensa$10,814,023
- Christine W Hockett · Avera Mckennan$8,908,366
- Michael E. Roth · Public Health Institute$8,201,777
- Jeff T Hutchins · Inhalon Biopharma, Inc.$8,127,032
Research focus
MortalityTrainingFutureMentorshipRheumatologistStage At DiagnosisDatabasesFundingMalignant NeoplasmsMentorsRheumatismRheumatoid ArthritisEvidence BaseSkillsClinical PracticeComorbidityCareer DevelopmentDiagnosisGeneral PopulationMalignant Neoplasm Of LungCancer DiagnosisCharacteristicsResearch PersonnelUnited States Department Of Veterans Affairs
Grant awards (7)
Improving shared decision-making around the use of disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer$163,014
K23 · FY2025 · AR · contact PI
Improving shared decision-making around the use of disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer$2,000
K23 · FY2025 · AR · contact PI
Improving shared decision-making around the use of disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer$164,617
K23 · FY2024 · AR · contact PI
Impact of rheumatoid arthritis on survival in older adults with cancer$137,103
R03 · FY2024 · AG · contact PI
Improving shared decision-making around the use of disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer$164,924
K23 · FY2023 · AR · contact PI
Impact of rheumatoid arthritis on survival in older adults with cancer$151,525
R03 · FY2023 · AG · contact PI
Improving shared decision-making around the use of disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer$166,779
K23 · FY2022 · AR · contact PI